Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Unlocking Data            for Profitable                    Clinical Development                                          ...
For more information please send an email to or visit  The      Pharma        Network          -   ...
Upcoming SlideShare
Loading in …5

Unlocking Data for Profitable Clinical Development - Staffan Gestrelius & Jerker Ringstrom, Capish


Published on

Staffan Gestrelius and Jerker Ringstrom of Capish, a solution provider at the marcus evans Evolution Summit 2012 in North America and Evolution Summit 2012 in Europe, on unlocking the data of clinical trials for more profitable clinical development.
Interview with: Staffan Gestrelius, President and Chief Executive Officer & Jerker Ringstrom, Head of Business Development, Capish

Published in: Business, Education
  • Be the first to comment

  • Be the first to like this

Unlocking Data for Profitable Clinical Development - Staffan Gestrelius & Jerker Ringstrom, Capish

  1. 1. Unlocking Data for Profitable Clinical Development Staffan Gestrelius: Scientists need to then all of a sudden you have to focus probe and analyze data the way the on the patient and what genetic financial sector does. To make better patterns or biomarkers he reacts to, this decisions and learn more about their will be an important turning point in compounds and patients, they must drug development. unlock data throughout the study and not just at the end. This will become even more important with personalized medicine. How can clinical data become a Knowledge knowledge asset? directly impacts Jerker Ringstrom: One of the most important words in this space is profitability “knowledge”. To turn data into a knowledge asset, it must be put into perspective. Scientists need constant feedback when deciding whether to Can it help scientists be more continue with a program or to make innovative? How? amendments. Jerker Ringstrom: Scientists can get If you look at a clinical trial protocol, it new ideas for indications by better usually mirrors the situation of the analyzing data. More drugs today are study six to eight months before it being used in new formulations and for ended. This means there was time to new indications, but finding these newInterview with: Staffan Gestrelius, make valuable changes to the design indications is proving to be challenging.President and Chief Executive and improve the quality of the trial.Officer & Jerker Ringstrom, Head of How is this approach moreBusiness Development, Capish How could this enhance safety? profitable? Staffan Gestrelius: If you have a system Staffan Gestrelius: This will be aScientists must unlock and analyze data that continuously watches over patients knowledge game. It will become crucialthroughout the clinical trial, according and gives you access to graphs and to know everything about a specificto Staffan Gestrelius, President and statistics, you can keep track of adverse drug. This approach is more profitableChief Executive Officer and Jerker events and drug associated adverse because people are not willing to pay forRingstrom, Head of Business effects. The earlier this is done, the a drug that only has a 50 per centDevelopment, Capish. From a solution better. chance of curing them. The reason whyprovider company at the marcus evans many companies are troubled today isEvolution Summit 2012, in North Jerker Ringstrom: This also helps because they do not have good enoughAmerica and the Evolution Summit pharmaceutical companies be patient treatments.2012 in Europe, Gestrelius and centric. When you develop a new drug,Ringstrom discuss how knowledge you need to come up with a diagnostic Knowledge directly impacts profitability.directly impacts the profitability of tool. The patient plays a more central Pharmaceutical companies should focusclinical development. role than before, as the diagnosis will be more on knowledge than on showing the torch through the darkness. I that the drug is not dangerous, simplyWhat role can Business Intelligence emphasize darkness, because when you to get it approved by the FDA. This willtools play in clinical development? focus on means and standard deviations not be enough.
  2. 2. For more information please send an email to or visit The Pharma Network - the event websites below: marcus evans Summits group delivers peer-to-peer information Evolution Summit 2012 - North America: on strategic matters, professional trends and breakthrough Evolution Summit 2012 - Europe: innovations. Contact Please note that the Summit is a Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits closed business event and the Division number of participants strictly Tel: + 357 22 849 313 limited. Email: All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to press@marcusevanscy.comAbout CapishCapish is a Swedish Knowledge Management Service Organisation founded in 2001. We can give non-data literate expertsimmediate access to all clinical and non-clinical information through easy-to-use web-based interactive graphical interfaces forsearching and also interactive statistical tools for analyses. Capish will shortly be available for prospective trials.www.capishknowledge.comAbout marcus evans Summitsmarcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discussstrategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity toindividually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings.For more information, please visit: www.marcusevans.comUpcoming EventsDiscovery Summit (Europe) - www.discovery-summit.comDiscovery Summit (North America) - www.thediscoverysummit.comEvolution Summit (Europe) - www.evolution-summit.comEvolution Summit (North America) - www.evolutionsummit.comTo view the web version of this interview please click